We aimed to assess the safety and efficacy of simplifying the treatment regimen for adults with virologically suppressed HIV infection from a ritonavir-boosted protease inhibitor and emtricitabine plus tenofovir disoproxil fumarate ( tenofovir ) regimen to coformulated elvitegravir , cobicistat , emtricitabine , and tenofovir .